The Pharma Career Ladder · The first-line manager · Step 8: Managing up and growing · Lesson 5

Decisions you should not escalate

Owning the call that is yours to make

By Ahmed El Menshawy · 20 years in pharma, from medical rep to country manager in the UAE. Founder of RepPharma. LinkedIn
Published

"Let me check with my manager."

Sometimes that is exactly the right answer. Often, in my experience, it is a decision the first-line manager could have made in five minutes.

Escalating feels safe. If someone above you decides, it is not your mistake. But the cost lands on the team. Reps learn to wait. The customer waits too. And your own manager starts to wonder what they are paying you to decide.

Before I send a question upward, I run it through four steps.

Is it mine to decide? Field days, call plans, coaching focus, who joins which visit. If it sits within my role, I decide it.

Do I have the facts? Ask the rep, check the data, see the account myself. Most decisions need an hour, not a committee.

Decide and explain. Make the call, then tell the team why. A clear reason matters more than a perfect answer, and I can correct a decision later if I was wrong.

Escalate only what is not mine. Compliance, pricing, contracts and anything outside policy go up, every time. When they do, I bring the facts and a recommendation, not just the question.

“Escalate what is not yours. Own what is.”
Decisions you should not escalate: Owning the call that is yours to make

Lesson 5 of 6 in Step 8: Managing up and growing, with the full guide and a checklist for this week.

More lessons in step 8: Managing up and growing

Managing up and growing, in RepPharma

Plans approved in one click

Each rep’s monthly plan is drafted from doctor priority and visit frequency; you review and approve it in one click.

Team reviews that assemble themselves

Monthly team reviews are built from field data, and a month-end checklist shows which reps have next month’s plan, forecast and expenses in.

Forecasts graded against real sales

Bottom-up forecasts per account and product are graded against real sales every month.

A new step every week in the Pharma Career Ladder newsletter on LinkedIn.